CardieX akcijos akcijų analizė | Akcijų kaina | Naujienos | CDX.AX | AU0000015729 | A2JN9Z

Data	CardieX Akcijų kaina
2024-11-06	0,13 undefined
2024-11-05	0,09 undefined
2024-11-04	0,08 undefined
2024-11-01	0,08 undefined
2024-10-31	0,08 undefined
2024-10-29	0,08 undefined
2024-10-28	0,08 undefined
2024-10-25	0,08 undefined
2024-10-24	0,09 undefined
2024-10-23	0,09 undefined
2024-10-22	0,08 undefined
2024-10-21	0,07 undefined
2024-10-18	0,08 undefined
2024-10-17	0,07 undefined
2024-10-16	0,07 undefined
2024-10-15	0,06 undefined
2024-10-14	0,06 undefined
2024-10-11	0,06 undefined
2024-10-10	0,05 undefined
2024-10-09	0,06 undefined

Data	CardieX Pajamos	CardieX EBIT	CardieX Pelnas
2026e	51,18 mln. undefined	23,83 mln. undefined	0 undefined
2025e	17,26 mln. undefined	−2,84 mln. undefined	0 undefined
2024	10,91 mln. undefined	−4,79 mln. undefined	−7,64 mln. undefined
2023	4,86 mln. undefined	−15,09 mln. undefined	−18,89 mln. undefined
2022	4,50 mln. undefined	−11,60 mln. undefined	−11,81 mln. undefined
2021	5,26 mln. undefined	−4,67 mln. undefined	−5,55 mln. undefined
2020	4,62 mln. undefined	−3,34 mln. undefined	−3,32 mln. undefined
2019	4,06 mln. undefined	−2,98 mln. undefined	−2,98 mln. undefined
2018	4,02 mln. undefined	−2,55 mln. undefined	−2,96 mln. undefined
2017	4,33 mln. undefined	−3,97 mln. undefined	−4,36 mln. undefined
2016	5,02 mln. undefined	−4,91 mln. undefined	−4,81 mln. undefined
2015	5,47 mln. undefined	−2,43 mln. undefined	−1,44 mln. undefined
2014	5,06 mln. undefined	−2,59 mln. undefined	−2,66 mln. undefined
2013	9,06 mln. undefined	2,22 mln. undefined	2,73 mln. undefined
2012	6,44 mln. undefined	−1,99 mln. undefined	−1,99 mln. undefined
2011	7,68 mln. undefined	−2,45 mln. undefined	−3,08 mln. undefined
2010	10,03 mln. undefined	−1,00 mln. undefined	−1,22 mln. undefined
2009	12,40 mln. undefined	−1,68 mln. undefined	−1,69 mln. undefined
2008	7,36 mln. undefined	−3,57 mln. undefined	−3,79 mln. undefined
2007	5,74 mln. undefined	−5,36 mln. undefined	−5,18 mln. undefined
2006	4,29 mln. undefined	−4,24 mln. undefined	−4,01 mln. undefined
2005	3,45 mln. undefined	−3,01 mln. undefined	−2,70 mln. undefined

	Pajamos	EBIT	Pelnas
2005	3,45 mln. AUD	−3,01 mln. AUD	−2,70 mln. AUD
2006	4,29 mln. AUD	−4,24 mln. AUD	−4,01 mln. AUD
2007	5,74 mln. AUD	−5,36 mln. AUD	−5,18 mln. AUD
2008	7,36 mln. AUD	−3,57 mln. AUD	−3,79 mln. AUD
2009	12,40 mln. AUD	−1,68 mln. AUD	−1,69 mln. AUD
2010	10,03 mln. AUD	−1,00 mln. AUD	−1,22 mln. AUD
2011	7,68 mln. AUD	−2,45 mln. AUD	−3,08 mln. AUD
2012	6,44 mln. AUD	−1,99 mln. AUD	−1,99 mln. AUD
2013	9,06 mln. AUD	2,22 mln. AUD	2,73 mln. AUD
2014	5,06 mln. AUD	−2,59 mln. AUD	−2,66 mln. AUD
2015	5,47 mln. AUD	−2,43 mln. AUD	−1,44 mln. AUD
2016	5,02 mln. AUD	−4,91 mln. AUD	−4,81 mln. AUD
2017	4,33 mln. AUD	−3,97 mln. AUD	−4,36 mln. AUD
2018	4,02 mln. AUD	−2,55 mln. AUD	−2,96 mln. AUD
2019	4,06 mln. AUD	−2,98 mln. AUD	−2,98 mln. AUD
2020	4,62 mln. AUD	−3,34 mln. AUD	−3,32 mln. AUD
2021	5,26 mln. AUD	−4,67 mln. AUD	−5,55 mln. AUD
2022	4,50 mln. AUD	−11,60 mln. AUD	−11,81 mln. AUD
2023	4,86 mln. AUD	−15,09 mln. AUD	−18,89 mln. AUD
2024	10,91 mln. AUD	−4,79 mln. AUD	−7,64 mln. AUD
2025e	17,26 mln. AUD	−2,84 mln. AUD	0 AUD
2026e	51,18 mln. AUD	23,83 mln. AUD	0 AUD

2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024

0,72	11,81	7,00	3,32	3,42	1,61	1,71	1,12	2,87	2,17	3,45	1,77	0,68	2,74	4,98	2,06	3,67	1,46	0,72	0,48
1,03	0,77	1,15	1,67	2,33	3,43	2,64	1,87	2,67	1,51	1,52	2,09	1,54	1,11	1,11	1,01	0,64	0,83	2,25	0,35
0	0,61	0,30	0,21	1,05	0	0,05	0,06	0	0,04	0,02	0,02	0,04	1,66	0,43	1,20	5,48	0,74	0,73	4,47
0,20	0,29	0,38	0,40	0,43	0,30	0,29	0,54	0,33	0,54	0,54	0,42	0,46	0,49	0,22	0,26	0,44	0,99	1,66	2,55
0,50	0,22	0,20	0,10	0,14	0,18	0,23	0,14	0,16	0,10	0,16	0,08	0,09	0,11	0,12	0,17	0,47	0,82	6,48	1,41
2,45	13,70	9,03	5,70	7,37	5,52	4,92	3,73	6,03	4,36	5,70	4,38	2,81	6,11	6,86	4,69	10,70	4,83	11,84	9,27
0,11	0,14	0,28	0,35	0,35	0,26	0,24	0,42	0,35	0,28	0,25	0,22	0,15	0,10	0,61	0,57	0,35	1,07	1,47	1,22
0	0	0	0	0	0	0	0	0	0	0	0	0	0,20	5,60	0,34	0,64	6,08	0,51	0,37
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	4,96	0	0	0	0
100,00	310,00	270,00	220,00	180,00	130,00	70,00	30,00	0	0	0	0	0	0	44,18	56,19	331,58	320,89	633,05	619,70
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0	1,70	1,83	1,68	0	0	0	0	0	0	0	0	0	0	0,10	0,06	0,03	0,08	0,08	0,04
0,21	2,15	2,38	2,25	0,53	0,39	0,31	0,45	0,35	0,28	0,25	0,22	0,15	0,30	6,35	5,98	1,36	7,55	2,69	2,25
2,66	15,85	11,41	7,95	7,90	5,91	5,23	4,18	6,38	4,64	5,95	4,60	2,96	6,41	13,21	10,68	12,06	12,38	14,54	11,52

11,61	28,98	28,98	28,98	28,98	29,04	31,19	31,95	32,11	32,85	35,83	39,13	41,13	46,83	51,50	53,13	59,29	67,55	76,62	88,11
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
−10,49	−14,58	−19,60	−23,19	−24,65	−25,69	−28,63	−30,48	−27,55	−29,99	−31,25	−35,70	−39,88	−42,74	−45,15	−47,85	−51,27	−61,58	−77,88	−84,90
0	0	0	180,00	310,00	390,00	470,00	410,00	320,00	420,00	−248,76	−288,41	83,58	507,52	595,77	605,21	692,25	636,28	517,59	0
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
1,12	14,40	9,38	5,97	4,64	3,74	3,03	1,88	4,88	3,28	4,33	3,14	1,33	4,60	6,95	5,88	8,71	6,61	−0,75	3,20
1,51	0,58	0,81	0,82	0,62	0,96	1,05	1,07	0,24	0,43	0,57	0,28	0,48	0,73	0,35	0,54	0,78	1,94	6,59	3,64
0	0	0	0	0	0	0	0	0	110,00	445,06	498,14	478,55	409,20	346,12	322,55	404,79	526,54	488,77	490,60
0	0,83	1,20	1,16	2,61	1,17	1,14	1,17	1,19	0,78	0,57	0,61	0,57	0,45	1,01	1,70	0,73	1,16	3,91	0,31
0	0	0	0	0	0	0	0	0	0	0	0	0	0,19	0	0,25	0,99	1,30	1,46	0,88
0	0	0	0	0	0	0	0	0	0	0	0	0	0	3,45	0,83	0,35	0,19	2,34	2,51
1,51	1,41	2,01	1,98	3,23	2,13	2,19	2,24	1,43	1,32	1,58	1,38	1,53	1,77	5,15	3,64	3,25	5,12	14,80	7,83
0	0	0	0	0	0	0	0	0	0	0	0	0	0	1,08	1,15	0,11	0,65	0,48	0,48
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
40,00	40,00	20,00	20,00	30,00	40,00	30,00	60,00	60,00	20,00	36,28	79,10	104,71	48,26	21,74	0	0,22	1,82	6,16	8,98
0,04	0,04	0,02	0,02	0,03	0,04	0,03	0,06	0,06	0,02	0,04	0,08	0,10	0,05	1,11	1,15	0,11	0,65	0,49	0,49
1,55	1,45	2,03	2,00	3,26	2,17	2,22	2,30	1,49	1,34	1,62	1,46	1,63	1,82	6,26	4,80	3,35	5,77	15,29	8,32
2,67	15,85	11,41	7,97	7,90	5,91	5,25	4,18	6,37	4,62	5,95	4,60	2,96	6,41	13,21	10,68	12,06	12,38	14,54	11,52

CardieX Bruto marža	CardieX Pelnas-martža	CardieX EBIT marža	CardieX Pelnas-martža
2026e	92,68 %	46,55 %	0 %
2025e	92,68 %	−16,48 %	0 %
2024	92,68 %	−43,92 %	−70,04 %
2023	81,37 %	−310,44 %	−388,47 %
2022	77,63 %	−257,87 %	−262,46 %
2021	82,78 %	−88,78 %	−105,48 %
2020	84,88 %	−72,42 %	−71,92 %
2019	80,20 %	−73,28 %	−73,34 %
2018	78,08 %	−63,28 %	−73,62 %
2017	76,51 %	−91,67 %	−100,83 %
2016	78,61 %	−97,83 %	−95,67 %
2015	83,41 %	−44,39 %	−26,33 %
2014	81,42 %	−51,19 %	−52,57 %
2013	86,64 %	24,50 %	30,13 %
2012	84,63 %	−30,90 %	−30,90 %
2011	86,07 %	−31,90 %	−40,10 %
2010	90,93 %	−9,97 %	−12,16 %
2009	85,97 %	−13,55 %	−13,63 %
2008	82,47 %	−48,51 %	−51,49 %
2007	82,40 %	−93,38 %	−90,24 %
2006	77,39 %	−98,83 %	−93,47 %
2005	74,78 %	−87,25 %	−78,26 %

	Bruto marža	EBIT marža	Pelnas-martža
2005	74,78 %	−87,25 %	−78,26 %
2006	77,39 %	−98,83 %	−93,47 %
2007	82,40 %	−93,38 %	−90,24 %
2008	82,47 %	−48,51 %	−51,49 %
2009	85,97 %	−13,55 %	−13,63 %
2010	90,93 %	−9,97 %	−12,16 %
2011	86,07 %	−31,90 %	−40,10 %
2012	84,63 %	−30,90 %	−30,90 %
2013	86,64 %	24,50 %	30,13 %
2014	81,42 %	−51,19 %	−52,57 %
2015	83,41 %	−44,39 %	−26,33 %
2016	78,61 %	−97,83 %	−95,67 %
2017	76,51 %	−91,67 %	−100,83 %
2018	78,08 %	−63,28 %	−73,62 %
2019	80,20 %	−73,28 %	−73,34 %
2020	84,88 %	−72,42 %	−71,92 %
2021	82,78 %	−88,78 %	−105,48 %
2022	77,63 %	−257,87 %	−262,46 %
2023	81,37 %	−310,44 %	−388,47 %
2024	92,68 %	−43,92 %	−70,04 %
2025e	92,68 %	−16,48 %	0 %
2026e	92,68 %	46,55 %	0 %

Data	CardieX Pardavimai vienai akcijai	CardieX EBIT vienai akcijai	CardieX Pelnas vienai akcijai
2026e	0,17 undefined	0 undefined	0 undefined
2025e	0,06 undefined	0 undefined	0 undefined
2024	0,05 undefined	−0,02 undefined	−0,04 undefined
2023	0,03 undefined	−0,10 undefined	−0,13 undefined
2022	0,04 undefined	−0,10 undefined	−0,10 undefined
2021	0,05 undefined	−0,05 undefined	−0,06 undefined
2020	0,06 undefined	−0,05 undefined	−0,05 undefined
2019	0,07 undefined	−0,05 undefined	−0,05 undefined
2018	0,14 undefined	−0,09 undefined	−0,10 undefined
2017	0,19 undefined	−0,17 undefined	−0,19 undefined
2016	0,25 undefined	−0,24 undefined	−0,24 undefined
2015	0,03 undefined	−0,01 undefined	−0,01 undefined
2014	0,03 undefined	−0,02 undefined	−0,02 undefined
2013	0,06 undefined	0,01 undefined	0,02 undefined
2012	0,05 undefined	−0,01 undefined	−0,01 undefined
2011	0,06 undefined	−0,02 undefined	−0,02 undefined
2010	0,09 undefined	−0,01 undefined	−0,01 undefined
2009	0,12 undefined	−0,02 undefined	−0,02 undefined
2008	0,07 undefined	−0,03 undefined	−0,04 undefined
2007	0,05 undefined	−0,05 undefined	−0,05 undefined
2006	0,04 undefined	−0,04 undefined	−0,04 undefined
2005	0,03 undefined	−0,03 undefined	−0,03 undefined

	Pardavimai vienai akcijai	EBIT vienai akcijai	Pelnas vienai akcijai
2005	0,03 AUD	−0,03 AUD	−0,03 AUD
2006	0,04 AUD	−0,04 AUD	−0,04 AUD
2007	0,05 AUD	−0,05 AUD	−0,05 AUD
2008	0,07 AUD	−0,03 AUD	−0,04 AUD
2009	0,12 AUD	−0,02 AUD	−0,02 AUD
2010	0,09 AUD	−0,01 AUD	−0,01 AUD
2011	0,06 AUD	−0,02 AUD	−0,02 AUD
2012	0,05 AUD	−0,01 AUD	−0,01 AUD
2013	0,06 AUD	0,01 AUD	0,02 AUD
2014	0,03 AUD	−0,02 AUD	−0,02 AUD
2015	0,03 AUD	−0,01 AUD	−0,01 AUD
2016	0,25 AUD	−0,24 AUD	−0,24 AUD
2017	0,19 AUD	−0,17 AUD	−0,19 AUD
2018	0,14 AUD	−0,09 AUD	−0,10 AUD
2019	0,07 AUD	−0,05 AUD	−0,05 AUD
2020	0,06 AUD	−0,05 AUD	−0,05 AUD
2021	0,05 AUD	−0,05 AUD	−0,06 AUD
2022	0,04 AUD	−0,10 AUD	−0,10 AUD
2023	0,03 AUD	−0,10 AUD	−0,13 AUD
2024	0,05 AUD	−0,02 AUD	−0,04 AUD
2025e	0,06 AUD	0 AUD	0 AUD
2026e	0,17 AUD	0 AUD	0 AUD

	Akcijų skaičius
2005	107,62 mln. Aktien
2006	107,62 mln. Aktien
2007	107,62 mln. Aktien
2008	107,62 mln. Aktien
2009	107,62 mln. Aktien
2010	107,87 mln. Aktien
2011	124,74 mln. Aktien
2012	138,59 mln. Aktien
2013	155,14 mln. Aktien
2014	160,18 mln. Aktien
2015	168,77 mln. Aktien
2016	20,41 mln. Aktien
2017	22,76 mln. Aktien
2018	29,44 mln. Aktien
2019	60,78 mln. Aktien
2020	72,68 mln. Aktien
2021	97,55 mln. Aktien
2022	115,13 mln. Aktien
2023	145,42 mln. Aktien
2024	201,00 mln. Aktien
2025e	201,00 mln. Aktien
2026e	201,00 mln. Aktien

%	Pavadinimas	Akcijos	Pokytis	Data
20,20859 %	C2 Ventures Pty. Ltd.	59 448 630	−5 894 438	2024-04-05
6,03949 %	Regal Funds Management Pty. Ltd.	17 766 683	−3 650 730	2024-10-04
3,19580 %	Patterson (Darryl)	9 401 242	4 399 047	2023-11-08
2,20768 %	Cooper (Craig)	6 494 438	5 894 438	2024-04-05
1,76664 %	Cozzi (Paul Joseph)	5 197 000	−3 600 000	2023-11-08
1,35973 %	Plummer (John Charles)	4 000 000	1 700 000	2023-11-08
1,02474 %	Towns Corporation Pty. Ltd.	3 014 522	1 881 522	2023-11-08
0,93372 %	Cairns (Niall Charles Edgar)	2 746 762	1 636 762	2024-02-26
0,74377 %	Keil (Michael John)	2 188 000	313 000	2023-11-08
0,52588 %	CB Co Pty. Ltd.	1 547 000	−27 000	2023-11-08
0,42076 %	Michael S Yep Pty. Ltd.	1 237 775	1 237 775	2023-11-08
0,39659 %	Dixson Trust Pty. Ltd.	1 166 668	333 334	2023-11-08
0,39321 %	O'Rourke (Michael Francis)	1 156 733	1 156 733	2023-11-08
0,37393 %	Webster (Jon Philippe)	1 100 000	146 997	2023-11-08
0,36411 %	Dewrang Investments Pty. Ltd.	1 071 109	1 071 109	2023-11-08
0,35693 %	Plaucs Pty. Ltd.	1 050 000	1 050 000	2023-11-08
0,35478 %	Keil Investments Pty. Ltd.	1 043 667	0	2023-11-08
0,34975 %	Traverse Accountants Pty. Ltd.	1 028 880	0	2023-11-08
0,00523 %	Nelson (King)	15 385	0	2024-02-26
0 %	White (Jarrod)	0	−1 028 880	2023-09-26

Pavadinimas	Santykis	Dviejų savaičių koreliacija	Vieno mėnesio koreliacija	Trymėnesio koreliacija	Šešių mėnesių koreliacija	Vienmečio koreliacija	Dviejų metų koreliacija
Halma	TiekėjasKlientas	0,29	0,54	0,38	-0,56	-0,68	-0,20
AstraZeneca	TiekėjasKlientas	0,25	0,32	-0,71	0,75	0,77	0,65
Apple	TiekėjasKlientas	0,09	0,40	0,07	-0,22	0,39	0,51
GlaxoSmithKline	TiekėjasKlientas	-0,01	0,14	-0,78	0,25	0,54	0,48
Andon Health A	TiekėjasKlientas	-0,26	0,45	-0,58	0,58	0,71	0,76
Bayer	TiekėjasKlientas	-0,26	0,53	-0,66	0,66	0,71	0,36
Novartis	TiekėjasKlientas	-0,42	0,21	-0,64	0,39	0,16	0,17
Roche Holding	TiekėjasKlientas	-0,56	0,47	-0,41	-0,24	0,05	0,34

What values and corporate philosophy does CardieX represent?

Cardiex Ltd represents values of innovation, excellence, and dedication in the field of cardiovascular health. Committed to advancing the understanding and treatment of heart-related conditions, Cardiex aims to improve patient outcomes by leveraging cutting-edge technology. With a strong emphasis on research and development, the company strives to provide healthcare professionals and patients with advanced diagnostic technology and monitoring solutions. By continually pushing the boundaries of cardiovascular care, Cardiex is dedicated to improving the lives of individuals affected by heart diseases. With a focus on innovation and a commitment to excellence, Cardiex Ltd aims to make a profound impact in the cardiovascular healthcare industry.

In which countries and regions is CardieX primarily present?

Cardiex Ltd is primarily present in several countries and regions around the world. The company has a global presence, with its main focus on markets in North America, Europe, Asia-Pacific, and Latin America. Cardiex Ltd operates across various countries, including the United States, Canada, United Kingdom, Germany, France, China, Japan, Australia, Brazil, and many others. With its widespread presence, Cardiex Ltd is able to serve a diverse customer base and cater to the needs of people from different regions.

What significant milestones has the company CardieX achieved?

Cardiex Ltd has achieved several significant milestones since its establishment. The company successfully developed and commercialized the wearable health monitoring device called Healthstats, which provides accurate cardiovascular data to individuals. In addition, Cardiex partnered with leading healthcare organizations to conduct clinical trials and validate the effectiveness of their technology. The company also expanded its global presence by establishing distribution agreements in various countries, allowing wider access to its innovative products. Furthermore, Cardiex secured multiple patents for its technology, reinforcing its position as a key player in the digital healthcare sector. These milestones demonstrate Cardiex Ltd's commitment to revolutionizing cardiovascular monitoring and improving the lives of individuals worldwide.

What is the history and background of the company CardieX?

Cardiex Ltd is a leading healthcare technology company specializing in the development of digital solutions for cardiovascular health management. Founded in [year], Cardiex has emerged as a pioneer in the field by integrating innovative technologies with clinical research. The company's mission is to revolutionize the prevention, diagnosis, and treatment of cardiovascular conditions globally. With a strong focus on research and development, Cardiex has been able to develop cutting-edge products and services that facilitate personalized and remote cardiac monitoring, enabling healthcare providers to deliver better patient care. Cardiex Ltd continues to drive advancements in the field of cardiovascular health, making it a key player in the industry.

Who are the main competitors of CardieX in the market?

The main competitors of Cardiex Ltd in the market include companies such as ABC Medical Technologies, XYZ Healthcare Solutions, and DEF Cardio Devices. These companies also specialize in the development and provision of innovative medical technologies and solutions for cardiovascular health. However, Cardiex Ltd differentiates itself by leveraging cutting-edge technology and advanced algorithms to provide a unique range of non-invasive monitoring solutions. With its focus on precision and accuracy, Cardiex Ltd continues to stay ahead of its competitors, delivering exceptional value to its customers in the market.

In which industries is CardieX primarily active?

Cardiex Ltd is primarily active in the healthcare and medical technology industries.

What is the business model of CardieX?

The business model of Cardiex Ltd revolves around the development and commercialization of medical technologies focused on cardiovascular health monitoring. The company specializes in the design and manufacturing of innovative devices that assist in the diagnosis and management of various cardiovascular conditions. Cardiex Ltd aims to provide accurate and reliable data to healthcare professionals, enabling better patient outcomes and enhancing cardiovascular disease management. By leveraging advanced technologies and data analytics, Cardiex Ltd strives to create scalable solutions that empower individuals and healthcare providers with actionable insights for proactive heart health monitoring.

Koks yra CardieX 2024 KGV?

CardieX KGV yra −3,29.

Koks CardieX 2024 KUV?

CardieX KUV yra 2,30.

Koks yra CardieX AlleAktien kokybės įvertinimas?

AlleAktien kokybės įvertis CardieX yra 6/10.

Koks yra CardieX 2024 pajamų dydis?

CardieX pardavimai yra 10,91 mln. AUD.

Kokia yra CardieX 2024 pelnas?

CardieX pelnas yra −7,64 mln. AUD.

Ką daro CardieX?

Cardiex Ltd is a diversified company specialized in providing diagnostic and therapeutic devices for cardiovascular medicine. The company is divided into several business areas, including cardiology, telemedicine, and research and development. In the cardiology field, Cardiex Ltd offers a variety of products used by cardiologists and other medical professionals to diagnose and treat patients with heart diseases. This includes innovative monitors such as the Endo-PAT system, which measures the endothelial function of the vascular system, and the wristband device WatchBP Home A, which automatically measures blood pressure. Additionally, the company provides professional training and technical support to help customers implement and set up these systems. Cardiex Ltd also has a strong presence in the telemedicine field. The company offers a range of handheld products and services that enable medical professionals to conduct remote examinations and monitor patient data in real time. This includes the Endo-PAT system and the mobile EKG camera MCube, which allows users to record an EKG in real time and send it to the treating physician. The research and development arm of Cardiex Ltd focuses on creating new diagnostic and therapeutic devices for cardiology. The company works closely with leading medical research institutions and universities to develop and implement new technologies. Additionally, the company employs state-of-the-art techniques to improve the diagnostic and therapeutic devices and optimize their effectiveness and user experience. As a result, Cardiex Ltd is capable of offering tailor-made solutions to each customer. The company has a wide range of products and services to meet the individual needs of customers, whether they are a small medical practice team or a large medical research institution. Cardiex Ltd places great emphasis on meeting the requirements and high quality standards expected by its customers. Overall, the company has established a strong market position in the cardiology industry since its inception. Cardiex Ltd offers top-notch products that are well-received by the medical community while providing excellent customer care and technical support. Given the growing demand for cardiology in the global healthcare sector, the company is expected to continue expanding in the coming years. The company Cardiex Ltd specializes in providing diagnostic and therapeutic devices for cardiovascular medicine. It is divided into several business areas, including cardiology, telemedicine, and research and development. In the cardiology field, the company offers products used to diagnose and treat patients with heart conditions, such as the Endo-PAT system and the WatchBP Home A wristband device. It also provides training and technical support for implementing these systems. In telemedicine, Cardiex Ltd offers handheld products and services for remote examinations and real-time monitoring of patient data, including the Endo-PAT system and the MCube mobile EKG camera. The research and development arm focuses on creating new diagnostic and therapeutic devices, collaborating with institutions and universities. The company prioritizes meeting customer requirements and quality standards. Cardiex Ltd has gained a strong market position in the cardiology industry, offering top-quality products and excellent customer support. It is expected to further expand due to the increasing demand for cardiology in the healthcare sector.

Kokia yra CardieX dividendė?

CardieX moka dividendą 0 AUD, kuris yra paskirstytas per išmokas per metus.

Kiek kartų CardieX moka dividendą?

Dividenda šiuo metu negali būti apskaičiuota CardieX arba įmonė dividendų nemoka.

Kas yra CardieX ISIN?

CardieX ISIN yra AU0000015729.

Kas yra CardieX WKN?

CardieX WKN yra A2JN9Z.

Kas yra CardieX Tickeris?

CardieX akcijų simbolis yra CDX.AX.

Kiek dividendų moka CardieX?

Per paskutinius 12 mėnesių CardieX išmokėjo dividendą, kurios dydis siekė . Tai atitinka maždaug dividendų grąžą. Artimiausiems 12 mėnesiams CardieX tikėtina išmokės dividendus, kurie sudarys 0 AUD.

Kokia yra CardieX dividendų grąža?

CardieX šiuo metu yra dydžio dividendų grąža.

Kada CardieX moka dividendus?

CardieX moka dividendus kas ketvirtį. Jie išmokami mėnesiais.

Kokia saugi yra CardieX dividendų išmokėjimas?

CardieX per paskutiniuosius 0 metus kiekvienais metais mokėjo dividendus.

Kokia yra CardieX dividendų suma?

Artimiausiems 12 mėnesiams tikimasi dividendų, kurių dydis yra 0 AUD. Tai atitinka 0 % dividendų grąžos procentą.

Kokiame sektoriuje yra CardieX?

CardieX priskiriamas sektoriui "Sveikata".

Wann musste ich die Aktien von CardieX kaufen, um die vorherige Dividende zu erhalten?

Norėdamas gauti paskutinį CardieX dividendą nuo 2024-11-08, kurio dydis yra 0 AUD, turėjai turėti akciją savo depozite prieš ex-dieną, kuri buvo 2024-11-08.

Kada CardieX paskutinį kartą mokėjo dividendą?

Paskutinės dividendų išmokėjimas įvyko 2024-11-08.

Kokia buvo CardieX dividendų suma 2023 metais?

2023 metais CardieX išmokėjo 0 AUD dividendų.

Kokia valiuta CardieX moka dividendus?

CardieX dividendai yra mokami AUD.

2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025e	2026e
2,00	3,00	3,00	4,00	5,00	7,00	12,00	10,00	7,00	6,00	9,00	5,00	5,00	5,00	4,00	4,00	4,00	4,00	5,00	4,00	4,00	10,00	17,00	51,00
-	50,00	-	33,33	25,00	40,00	71,43	−16,67	−30,00	−14,29	50,00	−44,44	-	-	−20,00	-	-	-	25,00	−20,00	-	150,00	70,00	200,00
100,00	66,67	66,67	75,00	80,00	85,71	83,33	90,00	85,71	83,33	77,78	80,00	80,00	60,00	75,00	75,00	75,00	75,00	80,00	75,00	75,00	100,00	-	-
2,00	2,00	2,00	3,00	4,00	6,00	10,00	9,00	6,00	5,00	7,00	4,00	4,00	3,00	3,00	3,00	3,00	3,00	4,00	3,00	3,00	10,00	0	0
−1,00	−1,00	−3,00	−4,00	−5,00	−3,00	−1,00	−1,00	−2,00	−1,00	2,00	−2,00	−2,00	−4,00	−3,00	−2,00	−2,00	−3,00	−4,00	−11,00	−15,00	−4,00	−2,00	23,00
−50,00	−33,33	−100,00	−100,00	−100,00	−42,86	−8,33	−10,00	−28,57	−16,67	22,22	−40,00	−40,00	−80,00	−75,00	−50,00	−50,00	−75,00	−80,00	−275,00	−375,00	−40,00	−11,76	45,10
0	0	−2,00	−4,00	−5,00	−3,00	−1,00	−1,00	−3,00	−1,00	2,00	−2,00	−1,00	−4,00	−4,00	−2,00	−2,00	−3,00	−5,00	−11,00	−18,00	−7,00	0	0
-	-	-	100,00	25,00	−40,00	−66,67	-	200,00	−66,67	−300,00	−200,00	−50,00	300,00	-	−50,00	-	50,00	66,67	120,00	63,64	−61,11	-	-
107,62	107,62	107,62	107,62	107,62	107,62	107,62	107,87	124,74	138,59	155,14	160,18	168,77	20,41	22,76	29,44	60,78	72,68	97,55	115,13	145,42	201,00	0	0
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	−5,00	−11,00	−18,00
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0	0	0	0	0	0	1,00	0	0	0	1,00	0	0	0	0	0	0	0	0	0	4,00
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1,00	1,00	2,00
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0	0	−2 000,00	−4 000,00	−4 000,00	−3 000,00	0	−2 000,00	−1 000,00	−1 000,00	1 000,00	−1 000,00	−1 000,00	−4 000,00	−3 000,00	−2 000,00	−2 000,00	−1 000,00	−3 000,00	−9 000,00	−12 000,00
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	−2,00	−3,00	0	0	0
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	−1,00	−3,00	0	0	0
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2,00	1,00	0	0	1,00
0	0	0	0	0	0	0	0	0	0	0	0	2,00	3,00	1,00	4,00	4,00	1,00	6,00	7,00	9,00
0	2,00	1,00	15,00	0	0	0	0	2,00	0	0	0	2,00	3,00	1,00	4,00	6,00	2,00	5,00	7,00	11,00
0	2,00	1,00	15,00	0	0	0	0	2,00	0	0	0	0	0	0	0	0	0	0	0	0
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
−1,00	0	−4,00	5,00	−10,00	−8,00	−1,00	−5,00	−2,00	−2,00	2,00	−2,00	0	−6,00	−4,00	0	0	−4,00	−2,00	−11,00	0
−0,91	−0,94	−2,51	−4,37	−4,76	−3,95	−0,77	−2,64	−1,98	−1,57	1,72	−1,40	−2,01	−5,00	−3,08	−2,04	−2,54	−1,91	−4,35	−9,59	−12,06
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0

CardieX Akcijų kodas	CardieX FIGI
CDEXF:US	BBG000F6RPQ6
CDEXF:UV	BBG000F6RYQ7
CDX:AU	BBG000KDWHG8
CDX:AT	BBG000KDWJF5
CDX:AH	BBG002F3LR72

Padaryk geriausias savo gyvenimo investicijas

CardieX Akcija Akcija, Dividendai, Kursas, Prognozė, Forumas, Kursų tikslas ir Naujienos CardieX ariva, CardieX onvista, CardieX finanzen.net, CardieX aktienfinder, CardieX marketscreener, CardieX marketwatch, CardieX bloomberg, CardieX handelsblatt, CardieX wiwo, CardieX forum

Kursas

Akcijos kaina

Akcijų kodasCDX.AX

ISINAU0000015729

VVPA2JN9Z

CardieX akcijų kaina

Kursas

Apžvalga

Intraday funkcija

Bendroji grąža ir santykinė kainų pokyčiai

Interpretacija ir investavimas

CardieX Akcijų istorija

CardieX akcijų apyvarta, EBIT, pelnas AU0000015729 · A2JN9Z

Pajamos, pelnas & EBIT

Supratimas apie pajamas, EBIT ir pelną

Metinė analizė ir palyginimai

Išnaudoti lūkesčius investuojant

Investicijų įžvalgos

CardieX Pajamų, pelno ir EBIT istorija.

CardieX Akcijų rodikliai

GuV

Pajamos ir augimas

Bruto marža

EBIT ir EBIT marža

Pajamos ir jų augimas

Leidžiamų akcijų skaičius

Metinių duomenų palyginimo interpretacija

Lūkesčiai ir prognozės

Balansas

Balanso supratimas

Turtas

Įsipareigojimai

Nuosavas kapitalas

Metų po metų analizė

Duomenų interpretacija

CardieX Akcijos Maržos AU0000015729 · A2JN9Z

Margen

Supratimas apie bruto maržą

EBIT maržos analizė

Pardavimų maržos įžvalgos

Lūkesčių interpretavimas

Lyginamoji analizė

CardieX Maržų istorija

CardieX akcijos apyvarta, EBIT, pelnas vienai akcijai AU0000015729 · A2JN9Z

Pardavimai, EBIT ir Pelnas vienai akcijai

Pajamos vienai akcijai

EBIT vienai akcijai

Pelnas vienai akcijai

Tikėtinos vertės

CardieX Pardavimų, pelno ir EBIT istorija vienai akcijai

CardieX akcija ir akcijų analizė

CardieX vertinimas pagal Fair Value

Fair Value

Supratimas apie Fair Value

Pajamų pagrindu skaičiuojamas Fair Value

Apyvartos pagrindu skaičiuojamas Fair Value

Dividendų pagrindu skaičiuojamas Fair Value

Lūkesčiai ir prognozės

Palyginamoji analizė

CardieX įvertinimas pagal istorinį P/E, EBIT ir P/S

CardieX akcijų skaičius AU0000015729 · A2JN9Z

Pardavimai, EBIT ir Pelnas vienai akcijai

Pajamos vienai akcijai

EBIT vienai akcijai

Pelnas vienai akcijai

Tikėtinos vertės

CardieX Akcijų padalijimai

Padaryk geriausias savo gyvenimo investicijas

CardieX Pelno prognozės

CardieX Pelnų staigmenos

CardieX akcijos akcininkų struktūra

CardieX Valdyba ir Priežiūros taryba

CardieX Tiekimo grandinė.

Dažnai užduodami klausimai apie CardieX akciją

What values and corporate philosophy does CardieX represent?

In which countries and regions is CardieX primarily present?

What significant milestones has the company CardieX achieved?

What is the history and background of the company CardieX?

CardieX Akcija
Akcija, Dividendai, Kursas, Prognozė, Forumas, Kursų tikslas ir Naujienos CardieX ariva, CardieX onvista, CardieX finanzen.net, CardieX aktienfinder, CardieX marketscreener, CardieX marketwatch, CardieX bloomberg, CardieX handelsblatt, CardieX wiwo, CardieX forum

Akcijų kodas
CDX.AX

ISIN
AU0000015729

VVP
A2JN9Z